How to Buy sakar Shares on Fincept?
You can buy Sakar Healthcare Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
Stay informed with the latest announcements for Sakar, including updates on board meetings and corporate actions.
Date | Description | Download |
---|
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
---|---|---|---|---|---|---|
Sakar Healthcare Limited |
SAKAR |
INE732S01012 |
Annual General Meeting |
13 Sep 2024 |
10 |
N/A |
Sakar Healthcare Limited |
SAKAR |
INE732S01012 |
Annual General Meeting |
14 Sep 2023 |
10 |
N/A |
Sakar Healthcare Limited |
SAKAR |
INE732S01012 |
Annual General Meeting |
12 Sep 2022 |
10 |
N/A |
Sakar Healthcare Limited |
SAKAR |
INE732S01012 |
Annual General Meeting |
16 Sep 2021 |
10 |
N/A |
Sakar Healthcare Limited |
SAKAR |
INE732S01012 |
Annual General Meeting |
16 Sep 2020 |
10 |
N/A |
Symbol |
Date |
Description |
Industry |
---|---|---|---|
SAKAR |
02 Jan 2025, 14:06:49 |
General Updates |
N/A |
SAKAR |
31 Dec 2024, 14:49:31 |
Alteration Of Capital and Fund Raising-XBRL |
N/A |
SAKAR |
27 Dec 2024, 13:45:20 |
Conversion |
N/A |
SAKAR |
27 Dec 2024, 13:32:58 |
Outcome of Board Meeting |
N/A |
SAKAR |
27 Dec 2024, 13:10:49 |
Trading Window-XBRL |
N/A |
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
---|---|---|---|---|
Sakar Healthcare Limited |
SAKAR |
21 Oct 2024, 10:37:00 |
21 Oct 2024, 10:37:00 |
|
Sakar Healthcare Limited |
SAKAR |
17 Jul 2024, 16:14:00 |
17 Jul 2024, 16:14:00 |
|
Sakar Healthcare Limited |
SAKAR |
20 Apr 2024, 14:36:00 |
05 Feb 2025, 19:42:03 |
|
Sakar Healthcare Limited |
SAKAR |
20 Jan 2024, 14:45:00 |
20 Jan 2024, 15:15:00 |
|
Sakar Healthcare Limited |
SAKAR |
18 Oct 2023, 15:45:00 |
18 Oct 2023, 16:15:00 |
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
---|---|---|---|---|---|
Chairperson & Executive Director-MD |
01 Aug 1959 |
26 Mar 2004 |
01515296 |
Sanjay S Shah |
- |
Non-Executive Director |
21 Aug 1964 |
26 Mar 2004 |
01515340 |
Rita S. Shah |
- |
Executive Director-MD |
16 Feb 1991 |
01 Jun 2012 |
05294294 |
Aarsh S. Shah |
- |
Independent Director |
12 Apr 1961 |
01 Apr 2015 |
01835567 |
Shailesh B. Patel |
- |
Independent Director |
31 Mar 1979 |
01 Apr 2015 |
02257146 |
Prashant C. Srivastav |
- |
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
---|---|---|---|---|---|
SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 22-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . |
SAKAR |
N/A |
INE732S01012 |
Sakar Healthcare Limited |
17 Oct 2024, 16:33:25 |
SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
SAKAR |
N/A |
INE732S01012 |
Sakar Healthcare Limited |
08 Aug 2024, 14:11:03 |
Financial Results |
SAKAR |
N/A |
INE732S01012 |
Sakar Healthcare Limited |
14 May 2024, 15:57:22 |
Financial Results |
SAKAR |
N/A |
INE732S01012 |
Sakar Healthcare Limited |
02 Feb 2024, 14:03:03 |
SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 21-Nov-2023 to consider Fund raising. |
SAKAR |
N/A |
INE732S01012 |
Sakar Healthcare Limited |
16 Nov 2023, 14:59:02 |
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
---|---|---|---|---|---|---|
Financial Results |
SAKAR |
- |
INE732S01012 |
Sakar Healthcare Limited |
17 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
SAKAR |
- |
INE732S01012 |
Sakar Healthcare Limited |
08 Aug 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results |
SAKAR |
- |
INE732S01012 |
Sakar Healthcare Limited |
14 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
Financial Results |
SAKAR |
- |
INE732S01012 |
Sakar Healthcare Limited |
02 Feb 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Fund Raising/Other business matters |
SAKAR |
- |
INE732S01012 |
Sakar Healthcare Limited |
16 Nov 2023, 00:00:00 |
To consider Fund Raising and other business matters |
date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Long Term Equity Investment | Investmentsin Subsidiariesat Cost | Investment Properties | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Prepaid Assets | Inventory | Finished Goods | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Financial |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-30T00:00:00 | quarterly | 21,749,910.00 | 21,749,910.00 | 738,375,000.00 | 741,571,000.00 | 2,661,974,000.00 | 3,436,761,000.00 | 90,105,000.00 | 2,661,974,000.00 | 2,695,190,000.00 | 3,192,339,000.00 | 2,695,190,000.00 | 2,695,190,000.00 | 2,477,691,000.00 | 0.00 | 0.00 | 217,499,000.00 | 217,499,000.00 | 1,348,096,000.00 | 632,931,000.00 | 0.00 | 0.00 | 109,488,000.00 | 497,149,000.00 | 497,149,000.00 | 26,294,000.00 | 715,165,000.00 | 92,220,000.00 | 0.00 | 244,422,000.00 | 244,422,000.00 | 0.00 | 1,463,000.00 | 279,894,000.00 | 24,104,000.00 | 255,790,000.00 | 4,043,286,000.00 | 3,237,916,000.00 | 60,134,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33,216,000.00 | 33,216,000.00 | 0.00 | 3,141,560,000.00 | 0.00 | 3,141,560,000.00 | 8,509,000.00 | 3,133,051,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 805,270,000.00 | -20,000.00 | 0.00 | 338,581,000.00 | 0.00 | 0.00 | 772,000.00 | 221,265,000.00 | 239,399,000.00 | 0.00 | 0.00 | 5,273,000.00 | 2,077,000.00 | 3,196,000.00 | 0.00 |
2024-03-31T00:00:00 | quarterly | 21,749,910.00 | 21,749,910.00 | 790,937,000.00 | 793,516,000.00 | 2,608,740,000.00 | 3,416,827,000.00 | 0.00 | 2,608,740,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 48,000,000.00 | 805,356,000.00 | 1,559,542,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22,881,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39,990,000.00 | 12,360,000.00 | 243,966,000.00 | 243,966,000.00 | 1,950,000.00 | 0.00 | 274,534,000.00 | 0.00 | 0.00 | 0.00 | 3,170,461,000.00 | 96,000.00 | 3,006,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14,571,000.00 | 14,571,000.00 | 0.00 | 3,152,788,000.00 | -563,019,000.00 | 3,715,807,000.00 | 24,587,000.00 | 437,596,000.00 | 2,472,850,000.00 | 598,535,000.00 | 182,239,000.00 | 0.00 | 0.00 | 0.00 | 224,924,000.00 | 0.00 | 42,986,000.00 | 234,337,000.00 | 100,000.00 | 0.00 | 0.00 | -146,000.00 | 209,272,000.00 | 0.00 | 0.00 | 0.00 | 2,579,000.00 |
2024-03-31T00:00:00 | annual | 21,749,910.00 | 21,749,910.00 | 790,937,000.00 | 793,516,000.00 | 2,608,740,000.00 | 3,416,827,000.00 | 0.00 | 2,608,740,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 48,000,000.00 | 805,356,000.00 | 1,559,542,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22,881,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39,990,000.00 | 12,360,000.00 | 243,966,000.00 | 243,966,000.00 | 1,950,000.00 | 0.00 | 274,534,000.00 | 0.00 | 0.00 | 0.00 | 3,170,461,000.00 | 96,000.00 | 3,006,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14,571,000.00 | 14,571,000.00 | 0.00 | 3,152,788,000.00 | -563,019,000.00 | 3,715,807,000.00 | 24,587,000.00 | 437,596,000.00 | 2,472,850,000.00 | 598,535,000.00 | 182,239,000.00 | 0.00 | 0.00 | 0.00 | 224,924,000.00 | 0.00 | 42,986,000.00 | 234,337,000.00 | 100,000.00 | 0.00 | 0.00 | -146,000.00 | 209,272,000.00 | 0.00 | 0.00 | 0.00 | 2,579,000.00 |
2023-09-30T00:00:00 | quarterly | 0.00 | 0.00 | 681,196,000.00 | 682,290,000.00 | 2,369,355,000.00 | 3,051,645,000.00 | 106,463,000.00 | 2,369,355,000.00 | 2,369,355,000.00 | 2,997,708,000.00 | 2,369,355,000.00 | 2,369,355,000.00 | 2,155,856,000.00 | 0.00 | 0.00 | 213,499,000.00 | 213,499,000.00 | 1,204,129,000.00 | 736,286,000.00 | 0.00 | 0.00 | 88,443,000.00 | 628,353,000.00 | 628,353,000.00 | 19,490,000.00 | 467,843,000.00 | 144,260,000.00 | 0.00 | 53,937,000.00 | 53,937,000.00 | 0.00 | 3,385,000.00 | 178,761,000.00 | 0.00 | 178,761,000.00 | 3,573,484,000.00 | 2,999,178,000.00 | 169,890,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,826,282,000.00 | 0.00 | 2,826,282,000.00 | 76,981,000.00 | 2,749,301,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 574,306,000.00 | 146,334,000.00 | 0.00 | 223,335,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 201,476,000.00 | 0.00 | 0.00 | 3,161,000.00 | 2,067,000.00 | 1,094,000.00 | 0.00 |
2023-03-31T00:00:00 | quarterly | 19,040,000.00 | 19,040,000.00 | 1,190,847,000.00 | 1,191,780,000.00 | 1,733,472,000.00 | 2,925,252,000.00 | 14,241,000.00 | 1,733,472,000.00 | 1,733,472,000.00 | 2,715,752,000.00 | 1,733,472,000.00 | 1,733,472,000.00 | 1,543,071,000.00 | 688,647,000.00 | 860,442,000.00 | 190,400,000.00 | 190,400,000.00 | 1,629,908,000.00 | 1,084,991,000.00 | -1,000.00 | 16,978,000.00 | 85,734,000.00 | 982,280,000.00 | 982,280,000.00 | 16,978,000.00 | 544,917,000.00 | 34,405,000.00 | 15,100,000.00 | 209,500,000.00 | 209,500,000.00 | 2,949,000.00 | 2,950,000.00 | 260,880,000.00 | 15,100,000.00 | 260,880,000.00 | 3,363,380,000.00 | 2,804,223,000.00 | 93,000.00 | 3,006,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,801,124,000.00 | -383,482,000.00 | 3,184,606,000.00 | 134,835,000.00 | 392,572,000.00 | 2,028,379,000.00 | 575,463,000.00 | 53,357,000.00 | 0.00 | 559,158,000.00 | 0.00 | 149,200,000.00 | 153,975,000.00 | 29,219,000.00 | 124,756,000.00 | 0.00 | 149,200,000.00 | 220,757,000.00 | 0.00 | 0.00 | 35,226,000.00 | 34,293,000.00 | 933,000.00 | 933,000.00 |
2023-03-31T00:00:00 | annual | 19,040,000.00 | 19,040,000.00 | 1,190,847,000.00 | 1,191,780,000.00 | 1,733,472,000.00 | 2,925,252,000.00 | 14,241,000.00 | 1,733,472,000.00 | 1,733,472,000.00 | 2,715,752,000.00 | 1,733,472,000.00 | 1,733,472,000.00 | 1,543,071,000.00 | 688,647,000.00 | 860,442,000.00 | 190,400,000.00 | 190,400,000.00 | 1,629,908,000.00 | 1,084,991,000.00 | -1,000.00 | 16,978,000.00 | 85,734,000.00 | 982,280,000.00 | 982,280,000.00 | 16,978,000.00 | 544,917,000.00 | 34,405,000.00 | 15,100,000.00 | 209,500,000.00 | 209,500,000.00 | 2,949,000.00 | 2,950,000.00 | 260,880,000.00 | 15,100,000.00 | 260,880,000.00 | 3,363,380,000.00 | 2,804,223,000.00 | 93,000.00 | 3,006,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,801,124,000.00 | -383,482,000.00 | 3,184,606,000.00 | 134,835,000.00 | 392,572,000.00 | 2,028,379,000.00 | 575,463,000.00 | 53,357,000.00 | 0.00 | 559,158,000.00 | 0.00 | 149,200,000.00 | 153,975,000.00 | 29,219,000.00 | 124,756,000.00 | 0.00 | 149,200,000.00 | 220,757,000.00 | 0.00 | 0.00 | 35,226,000.00 | 34,293,000.00 | 933,000.00 | 933,000.00 |
2022-03-31T00:00:00 | annual | 17,118,000.00 | 17,118,000.00 | 928,319,000.00 | 928,617,000.00 | 1,274,514,000.00 | 2,203,131,000.00 | 32,487,000.00 | 1,274,514,000.00 | 1,274,514,000.00 | 2,124,586,000.00 | 1,274,514,000.00 | 1,274,514,000.00 | 1,103,467,000.00 | 561,061,000.00 | 546,162,000.00 | 171,180,000.00 | 171,180,000.00 | 1,403,131,000.00 | 935,376,000.00 | -1,000.00 | 14,379,000.00 | 70,926,000.00 | 850,072,000.00 | 850,072,000.00 | 14,379,000.00 | 467,755,000.00 | 29,934,000.00 | 31,388,000.00 | 78,545,000.00 | 78,545,000.00 | 470,000.00 | 470,000.00 | 305,042,000.00 | 31,256,000.00 | 305,042,000.00 | 2,677,645,000.00 | 2,177,403,000.00 | 1,000.00 | 8,130,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,169,273,000.00 | -233,623,000.00 | 2,169,273,000.00 | 122,725,000.00 | 2,046,548,000.00 | 1,351,622,000.00 | 542,470,000.00 | 53,357,000.00 | 0.00 | 500,242,000.00 | 2,000.00 | 145,227,000.00 | 141,834,000.00 | 25,647,000.00 | 116,187,000.00 | 0.00 | 145,228,000.00 | 141,823,000.00 | -101,000.00 | 141,924,000.00 | 71,358,000.00 | 71,060,000.00 | 298,000.00 | 298,000.00 |
2021-03-31T00:00:00 | annual | 15,618,000.00 | 15,618,000.00 | 425,147,000.00 | 425,972,000.00 | 977,221,000.00 | 1,410,494,000.00 | 4,540,000.00 | 977,221,000.00 | 984,522,000.00 | 1,369,024,000.00 | 984,522,000.00 | 984,522,000.00 | 0.00 | 409,393,000.00 | 420,504,000.00 | 156,180,000.00 | 156,180,000.00 | 793,402,000.00 | 460,711,000.00 | 0.00 | 7,931,000.00 | 68,278,000.00 | 384,502,000.00 | 384,502,000.00 | 0.00 | 332,691,000.00 | 22,151,000.00 | 29,474,000.00 | 41,470,000.00 | 41,470,000.00 | 266,000.00 | 0.00 | 197,798,000.00 | 0.00 | 197,798,000.00 | 1,777,924,000.00 | 1,440,692,000.00 | 1,000.00 | 8,162,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,301,000.00 | 7,301,000.00 | 0.00 | 1,425,228,000.00 | -144,249,000.00 | 1,569,477,000.00 | 741,559,000.00 | 170,837,000.00 | 433,271,000.00 | 170,453,000.00 | 53,357,000.00 | 0.00 | 337,231,000.00 | 0.00 | 55,691,000.00 | 156,973,000.00 | 34,981,000.00 | 121,992,000.00 | 0.00 | 0.00 | 123,742,000.00 | -29,000.00 | 123,771,000.00 | 825,000.00 | 0.00 | 825,000.00 | 825,000.00 |
2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 74,242,260.00 | 0.00 | 813,196,560.00 | 937,918,021.00 | 813,196,560.00 | 813,196,560.00 | 7,348,516.00 | 0.00 | 0.00 | 149,610,000.00 | 149,610,000.00 | 337,179,196.00 | 195,656,210.00 | 0.00 | 0.00 | 63,958,337.00 | 124,721,461.00 | 124,721,461.00 | 6,976,412.00 | 141,522,986.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15,548,635.00 | 54,405,966.00 | 1,150,375,756.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100,000.00 | 100,000.00 | 0.00 | 0.00 | 32,800,338.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 215,765,246.00 | 19,128,686.00 | 0.00 | 109,333,243.00 | 0.00 | 0.00 | 757,351.00 | 0.00 | 82,339,951.00 | -58,384.00 | 82,398,335.00 | 2,959,481.00 | 0.00 | 2,959,481.00 | 0.00 |
date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Purchase Of Business | Net Intangibles Purchase And Sale | Purchase Of Intangibles | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Net Income From Continuing Operations |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31T00:00:00 | annual | -350,933,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,656,000.00 | -1,000.00 | 933,000.00 | 3,724,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 244,669,000.00 | -1,173,607,000.00 | 1,010,256,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 66,910,000.00 | 0.00 | 0.00 | 969,000.00 | 179,535,000.00 | -1,480,000.00 | 0.00 | 0.00 |
2023-03-31T00:00:00 | annual | -488,512,000.00 | 0.00 | 982,280,000.00 | 333,500,000.00 | -821,952,000.00 | 913,000.00 | 1,000.00 | 278,000.00 | 634,000.00 | 410,960,000.00 | -1,000.00 | -54,172,000.00 | 333,500,000.00 | 333,500,000.00 | 132,209,000.00 | 0.00 | 0.00 | 132,209,000.00 | -850,072,000.00 | 982,280,000.00 | -743,766,000.00 | 40,151,000.00 | 38,035,000.00 | 38,035,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -821,952,000.00 | 0.00 | -821,952,000.00 | 333,440,000.00 | -42,658,000.00 | 5,972,000.00 | 137,612,000.00 | 1,151,000.00 | -44,161,000.00 | -12,141,000.00 | -79,088,000.00 | 54,748,000.00 | 155,000.00 | 149,860,000.00 | 0.00 | 149,860,000.00 | -2,128,000.00 | -1,268,000.00 | 168,761,000.00 |
2022-03-31T00:00:00 | annual | -109,077,000.00 | -19,621,000.00 | 937,129,000.00 | 78,840,000.00 | -355,457,000.00 | 101,337,000.00 | 0.00 | 2,959,000.00 | 98,378,000.00 | 320,332,000.00 | -1,000.00 | -19,047,000.00 | 78,840,000.00 | 78,840,000.00 | 260,539,000.00 | -19,621,000.00 | -19,621,000.00 | 280,160,000.00 | -434,168,000.00 | 937,129,000.00 | -468,334,000.00 | -112,877,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -355,457,000.00 | 141,895,000.00 | -355,457,000.00 | 246,380,000.00 | -7,257,000.00 | -25,464,000.00 | 27,802,000.00 | -34,656,000.00 | 25,901,000.00 | -4,764,000.00 | -41,432,000.00 | 8,410,000.00 | 29,000.00 | 80,583,000.00 | 7,302,000.00 | 80,583,000.00 | 0.00 | -1,185,000.00 | 190,079,000.00 |
2021-03-31T00:00:00 | annual | -322,568,000.00 | -120,631,000.00 | 381,170,000.00 | 78,840,000.00 | -468,335,000.00 | 825,000.00 | 1,000.00 | 3,059,000.00 | -2,235,000.00 | 320,332,000.00 | 0.00 | -19,047,000.00 | 78,840,000.00 | 78,840,000.00 | 260,539,000.00 | -19,621,000.00 | -19,621,000.00 | 280,160,000.00 | -101,010,000.00 | 381,170,000.00 | -468,334,000.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -468,335,000.00 | 0.00 | -468,335,000.00 | 145,767,000.00 | -7,257,000.00 | -68,325,000.00 | 27,802,000.00 | -34,641,000.00 | 25,901,000.00 | -47,640,000.00 | -41,432,000.00 | 8,410,000.00 | 29,000.00 | 80,583,000.00 | 25,499,000.00 | 55,084,000.00 | 0.00 | 0.00 | 132,327,000.00 |
2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 43,760.00 | -133,347,202.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34,809,448.00 | 0.00 | -17,333,577.00 | 43,760.00 | 43,760.00 | 52,099,265.00 | 0.00 | 0.00 | 52,099,265.00 | 0.00 | 0.00 | -224,052,825.00 | -1.00 | 0.00 | 0.00 | 0.00 | -100,000.00 | -100,000.00 | -3,558,669.00 | -3,558,669.00 | -129,788,533.00 | 0.00 | -129,788,533.00 | 0.00 | 0.00 | 0.00 | 10,636,967.00 | 12,186,870.00 | 11,193,521.00 | -40,770,040.00 | 7,154,709.00 | 0.00 | 0.00 | 70,798,059.00 | 0.00 | 0.00 | 0.00 | 0.00 | 122,269,083.00 |
date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Discontinuous Operations | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue | Net Income Extraordinary |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-31T00:00:00 | annual | 0.08 | 0.00 | 40.40 | 0.29 | 0.29 | 0.00 | 0.00 | 0.00 | 40.70 | 22.64 | -7.49 | 6.75 | 0.13 | 11.45 | 0.00 | 132.20 | 2.05 | 2.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 | -7.49 | 0.87 | 6.75 | 0.13 | 21.15 | 48.52 | 8.72 | 0.00 | 0.10 | 17.95 | 0.62 | 2.16 | 0.01 | 2.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
2023-03-31T00:00:00 | annual | -0.03 | 0.00 | 37.47 | -0.12 | -0.12 | 12.76 | 14.99 | 73.79 | 37.35 | 22.36 | -5.70 | 5.49 | 0.27 | 12.85 | 12.76 | 114.24 | 1.86 | 1.86 | 0.00 | 0.00 | 12.76 | 12.76 | 0.00 | 12.76 | 0.00 | 12.76 | 0.00 | 12.76 | 4.12 | 16.88 | 4.67 | -0.12 | 0.01 | 0.12 | -5.70 | 0.48 | 5.49 | 0.27 | 19.12 | 40.45 | 7.57 | 14.99 | 0.00 | 14.99 | 0.75 | 1.21 | 0.03 | 1.19 | 59.57 | 73.79 | 133.36 | 133.36 | 0.00 |
2022-03-31T00:00:00 | annual | 0.01 | 0.00 | 31.20 | 0.06 | 0.06 | 15.24 | 8.06 | 74.81 | 31.26 | 21.60 | -2.91 | 2.59 | 0.00 | 15.19 | 15.24 | 107.59 | 1.51 | 1.51 | 0.00 | 0.00 | 15.24 | 15.24 | 0.00 | 15.24 | 0.00 | 15.24 | 0.00 | 15.24 | 3.77 | 19.01 | 0.06 | 0.00 | 0.00 | 0.00 | -2.91 | 0.32 | 2.59 | 0.00 | 20.64 | 32.77 | 7.76 | 9.67 | 0.73 | 8.94 | 0.11 | 0.90 | 0.02 | 0.88 | 53.41 | 74.81 | 128.23 | 128.23 | 0.00 |
2021-03-31T00:00:00 | annual | 0.00 | 0.00 | 21.46 | 0.00 | 0.00 | 10.68 | 8.06 | 51.49 | 21.46 | 13.41 | -2.48 | 0.17 | 0.02 | 10.68 | 10.68 | 79.61 | 0.02 | 0.02 | 0.00 | 0.00 | 10.68 | 10.68 | 0.00 | 10.68 | 0.00 | 10.68 | 0.00 | 10.68 | 2.55 | 13.23 | 0.00 | 0.00 | 0.00 | 0.00 | -2.48 | 2.32 | 0.17 | 0.02 | 15.12 | 28.12 | 6.41 | 8.06 | 2.55 | 8.06 | 0.01 | 0.95 | 0.01 | 0.94 | 43.25 | 51.49 | 94.74 | 94.74 | 0.00 |
2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.62 | 7.08 | 43.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.62 | 9.62 | 0.00 | 9.62 | 0.00 | 9.62 | 0.00 | 9.62 | 2.60 | 12.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 39.46 | 43.52 | 82.98 | 82.98 | 0.00 |
Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
---|---|---|---|---|---|---|
2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
5.95
51.33614
1.2528661
N/A
664.35 Cr.
243.801
243.801
7.52%
43.14 Cr.
31.13
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
You can buy Sakar Healthcare Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
The market capitalization of Sakar Healthcare Limited is ₹664 Cr as of 05 Feb 2025.
The PE and PB ratios of Sakar Healthcare Limited are Not Available and 1.2528661 respectively as of 05 Feb 2025.
The 52-week high of Sakar Healthcare Limited is ₹479 as of 05 Feb 2025.
The 52-week low of Sakar Healthcare Limited is ₹279.85 as of 05 Feb 2025.
The Earnings Per Share (EPS) of Sakar Healthcare Limited is ₹5.95 as per the most recent quarterly results available on Fincept.
The Return on Equity (ROE) of Sakar Healthcare Limited is 7.52% as per the most recent financial year data. Explore more on Fincept.